We are live on ! Find out more
GF

Genworth Financial Portfolio holdings

AUM $486M
1-Year Est. Return 19.32%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+19.32%
3 Year Est. Return
+64.01%
5 Year Est. Return
+73.19%
10 Year Est. Return
–
AUM
$297M
AUM Growth
+$21.4M
Cap. Flow
+$386K
Cap. Flow %
0.13%
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$318K
2
ACLX
Arcellx
ACLX
+$68.5K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$884B
$268M 90.41%
601,470
– –
SPLV icon
2
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
$28.1M 9.46%
446,687
– –
MIRM icon
3
Mirum Pharmaceuticals
MIRM
$6.36B
$309K 0.1%
+11,939
New +$318K
ACLX
4
DELISTED
Arcellx
ACLX
$56.6K 0.02%
+1,791
New +$68.5K

Similar funds

PE
PCM Encore Aspen, Colorado $486M AUM
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return
ACM
Aljian Capital Management Carson City, Nevada $487M AUM 31.87% 1-Year Est. Return
LCWP
Legacy Capital Wealth Partners Little Rock, Arkansas $485M AUM 21.24% 1-Year Est. Return
UOIF
University of Illinois Foundation Champaign, Illinois $487M AUM 32.41% 1-Year Est. Return
HL
HeadInvest LLC Portland, Maine $488M AUM 14.33% 1-Year Est. Return
GRR
Golden Reserve Retirement Dublin, Ohio $485M AUM 19.33% 1-Year Est. Return
NFW
Noble Family Wealth Clearwater, Florida $484M AUM 18.07% 1-Year Est. Return

Genworth Financial's Q2 2023 Portfolio in Review

As of Q2 2023, Genworth Financial held 4 positions worth $297M, up 7.8% from $275M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Genworth Financial's Q2 2023 filing shows 2 new positions. Its largest new stake was Mirum Pharmaceuticals: 11,939 shares worth $309K.

By sector, the portfolio is most concentrated in Healthcare at 0.12% of assets.

  • Genworth Financial's largest Q2 2023 buy was Mirum Pharmaceuticals: 11,939 shares worth $309K.
  • Genworth Financial's ten largest holdings make up 100% of its $297M portfolio in Q2 2023.
  • Genworth Financial opened 2 new positions and closed 0 in Q2 2023.
  • Genworth Financial's portfolio value rose 7.8% quarter-over-quarter to $297M.

Based on Genworth Financial's 13F filing for Q2 2023, filed 27 Jul 2023.